Leiden Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine

- Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteins - No use of mRNA or vector technology - Better and direct immunization of mucosa against multiple

Related Keywords

Bilthoven ,Utrecht ,Netherlands ,Dublin ,Ireland ,Amsterdam ,Noord Holland ,Holland ,Dutch ,Leo Visser ,Luisj Cruz ,Mirjam Hartman ,Kostenloser Wertpapierhandel ,Luis Cruz ,Prnewswire Intravacc ,Ted Lavelle ,Life Sciences Health ,Health Holland ,Imaging Department ,Top Consortium For Knowledge ,Trinity College Dublin ,Melinda Gates Foundation ,Public Health ,Leiden University Medical Center ,Infectious Diseases Department ,Dutch Leiden University Medical Center ,Lifespring Life Sciences Communication ,Top Consortium ,Outer Membrane ,Life Sciences ,Groen Phd ,Chief Executive Officer ,Professor Ed Lavelle ,Dutch Utrecht Science Park ,Jan Groen ,Spring Life Sciences Communication ,Leiden ,Medical ,Center ,Intravacc ,Start ,Linical ,Trial ,Intranasal ,Corona ,Vaccine ,